‘There’s no place like home’ for Chesterford’s carnival goers
Brazil looks to Chesterford for international collaboration
New faces at Chesterford Research Park
Chesterford Research Park appoints Security Manager
Chesterford Research Park appoints Facilities Manager
International delegation visits Chesterford
Scientific Recruitment Consultancy Locates to Chesterford Research Park
Chesterford Research Park Summer 08 Newsletter
Bausch & Lomb and Galapagos sign agreement to collaborate on ophthalmic disease research
Global Glass Manufacturers Moves to Chesterford Research Park
Work begins on state-of-the-art laboratory
World Class Life Science Company Signs Pre-Let of 41,500 sq ft Laboratory at Chesterford
Chesterford Research Park Winter 07 Newsletter
Chesterford Continues its Rapid Expansion by Securing a World Class Occupier
Glaxosmithkline and Galapagos Enter Strategic Alliance to Develop Novel Antibacterials and Antivirals
Cellzome CEO appointed to the Board of the UK’s BioIndustry Association Cambridge, UK
CellCentric and Cancer Research Technology Collaborate on Epigenetic Discoveries
The Nucleus at Chesterford Research Park wins Prestigious Architectural Award
Saffron Walden 10k Run
CellCentric receives funding from Takeda Research Investment, Inc
Biotica Technology Limited Appoints Edward E. Hodgkin as Chief Executive Officer
Dr Peter Ringrose joins Biotica Board
BioFocus expands US operations following new AstraZeneca deal
Chesterford Research Park Gets Awarded for its Environmental Awareness
Sharp revenue increase and strong progress in research programs for Galapagos in the first half-year 2007
Galapagos NV announces Expanded Relationship with Astrazeneca plc
Chesterford Research Park Appoints Jeffersons Commercial to Mansion House Lettings Campaign
Minister for Science and Innovation Officially Opens the Newly Completed Chesterford Laboratory
Chesterford Research Park Offers Office Suites
Chesterford Research Park Summer 07Newsletter
CellCentric signs IP agreement with Massachusetts General Hospital
CellCentric Limited Hit Key Milestone
Galapagos announces new collaboration agreements and a management appointment
Scientific Founder Wins Prestigious Rosenstiel Award
The Mansion House at Chesterford – a Vari-Lease Solution to Small Office Space
Chesterford Research Park Launches its first Newsletter
Sosei R & D Takes Possession of New HQ Building at Chesterford Research Park
The Park does Comic Relief
Park Hosts A’Level Student Visit
Cellzome AG Receives First Milestone Payment for Alzheimer's Program from Ortho-McNeil Pharmaceutical, Inc.
Galapagos announces 2006 full year results
UK Biotechnology: roll up, roll up and buy
Illumina Announces the Completion of Its Acquisition of Solexa
CellCentric expands its epigenetic discovery network
Solexa Genome Analysis System Achieves 1G Performance Milestone
Galapagos acquires ProSkelia from ProStrakan and raises €31 million
Healthy Menus Earn Uttlesford Heartbeat Award
BioFocus DPI has landed a £2.27 million deal to supply and develop compounds for use in Danish pharmaceutical LEO Pharma’s antibacterial research programme.
Park Team Raise Over £500 for Children in Need - Friday 17th November 2006
Illumina signs definitive agreement to acquire solexa
The Caribbean Comes to The Nucleus
GEM Award Winner
Solexa Announces Sequencing of a Human X-Chromosome
Cellcentric to take Suite at Chesterford Research Park's Newly Refurbished Mansion House
Biotica Enters into a Research and License Agreement with Wyeth for Novel Rapamycin Analogs
Galapagos raises €11.1 million from new equity issue
Agents turn to clubs and mallets at Chesterford Research Park
Solexa appoints Blain Bowman and Roy Whitfield to Board of Directors
Solexa appoints Frank Oaks Vice President, DNA Sequencing Services
Galapagos announces sharp revenue increase and profitability of service division in its half-year 2006 results
Galapagos announces new collaboration with AstraZeneca
The Nucleus - The Networking Hub of South Cambridge
Rounders Tournament
Solexa Names Brock Siegel Chief Operating Officer
Galapagos and Cellzome in kinase drug discovery collaboration GEIF Event Solexa Announces Initial System Shipments Lipsovir® has entered phase III clinical study Galapagos completes acquisition of drug discovery service operations of Discovery Partners International Solexa Names Richard H. Lussier Vice President, Sales and Field Operations June 2006 Chesterford Research Park Leads the Way Medivir outlicenses two new antiviral projects to Tibotec and extends its research collaboration in HCV Galapagos to Acquire Drug Discovery Service Operations of Discovery Partners International Invitrogen and Solexa Collaborate to Supply Reagents for Next Generation Sequencing News from Medivir’s ongoing R&D day May 2006 Battle on the park.................. 2006!! Solexa Added to NASDAQ BioTech Index Solexa Reports First Quarter Financial Result Chesterford Hosts Annual ERBI Conference - Evening Event Chesterford Expands - 65,000 sq ft of Development Under Way April 2006 Nucleus Celebrates 1st Birthday March 2006 Galapagos enters a three-year collaboration with Roche Solexa Reports Fourth Quarter Financial Results Science week treats for after-school club Recovery Position - The first prelet in Cambridge in two years.... Arakis to Expand at Chesterford Research Park Galapagos Announces 2005 Annual Results February 2006 Solexa Transfers Listing to the Nasdaq National Market Solexa Announces Technical Milestones at the AGBT Conference Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
GEIF Event
Solexa Announces Initial System Shipments
Lipsovir® has entered phase III clinical study
Galapagos completes acquisition of drug discovery service operations of Discovery Partners International
Solexa Names Richard H. Lussier Vice President, Sales and Field Operations
Chesterford Research Park Leads the Way
Medivir outlicenses two new antiviral projects to Tibotec and extends its research collaboration in HCV
Galapagos to Acquire Drug Discovery Service Operations of Discovery Partners International Invitrogen and Solexa Collaborate to Supply Reagents for Next Generation Sequencing News from Medivir’s ongoing R&D day May 2006 Battle on the park.................. 2006!! Solexa Added to NASDAQ BioTech Index Solexa Reports First Quarter Financial Result Chesterford Hosts Annual ERBI Conference - Evening Event Chesterford Expands - 65,000 sq ft of Development Under Way April 2006 Nucleus Celebrates 1st Birthday March 2006 Galapagos enters a three-year collaboration with Roche Solexa Reports Fourth Quarter Financial Results Science week treats for after-school club Recovery Position - The first prelet in Cambridge in two years.... Arakis to Expand at Chesterford Research Park Galapagos Announces 2005 Annual Results February 2006 Solexa Transfers Listing to the Nasdaq National Market Solexa Announces Technical Milestones at the AGBT Conference Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Invitrogen and Solexa Collaborate to Supply Reagents for Next Generation Sequencing News from Medivir’s ongoing R&D day May 2006 Battle on the park.................. 2006!! Solexa Added to NASDAQ BioTech Index Solexa Reports First Quarter Financial Result Chesterford Hosts Annual ERBI Conference - Evening Event Chesterford Expands - 65,000 sq ft of Development Under Way April 2006 Nucleus Celebrates 1st Birthday March 2006 Galapagos enters a three-year collaboration with Roche Solexa Reports Fourth Quarter Financial Results Science week treats for after-school club Recovery Position - The first prelet in Cambridge in two years.... Arakis to Expand at Chesterford Research Park Galapagos Announces 2005 Annual Results February 2006 Solexa Transfers Listing to the Nasdaq National Market Solexa Announces Technical Milestones at the AGBT Conference Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
News from Medivir’s ongoing R&D day May 2006 Battle on the park.................. 2006!! Solexa Added to NASDAQ BioTech Index Solexa Reports First Quarter Financial Result Chesterford Hosts Annual ERBI Conference - Evening Event Chesterford Expands - 65,000 sq ft of Development Under Way April 2006 Nucleus Celebrates 1st Birthday March 2006 Galapagos enters a three-year collaboration with Roche Solexa Reports Fourth Quarter Financial Results Science week treats for after-school club Recovery Position - The first prelet in Cambridge in two years.... Arakis to Expand at Chesterford Research Park Galapagos Announces 2005 Annual Results February 2006 Solexa Transfers Listing to the Nasdaq National Market Solexa Announces Technical Milestones at the AGBT Conference Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Battle on the park.................. 2006!! Solexa Added to NASDAQ BioTech Index Solexa Reports First Quarter Financial Result Chesterford Hosts Annual ERBI Conference - Evening Event Chesterford Expands - 65,000 sq ft of Development Under Way April 2006 Nucleus Celebrates 1st Birthday March 2006 Galapagos enters a three-year collaboration with Roche Solexa Reports Fourth Quarter Financial Results Science week treats for after-school club Recovery Position - The first prelet in Cambridge in two years.... Arakis to Expand at Chesterford Research Park Galapagos Announces 2005 Annual Results February 2006 Solexa Transfers Listing to the Nasdaq National Market Solexa Announces Technical Milestones at the AGBT Conference Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Solexa Added to NASDAQ BioTech Index Solexa Reports First Quarter Financial Result Chesterford Hosts Annual ERBI Conference - Evening Event Chesterford Expands - 65,000 sq ft of Development Under Way April 2006 Nucleus Celebrates 1st Birthday March 2006 Galapagos enters a three-year collaboration with Roche Solexa Reports Fourth Quarter Financial Results Science week treats for after-school club Recovery Position - The first prelet in Cambridge in two years.... Arakis to Expand at Chesterford Research Park Galapagos Announces 2005 Annual Results February 2006 Solexa Transfers Listing to the Nasdaq National Market Solexa Announces Technical Milestones at the AGBT Conference Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Solexa Reports First Quarter Financial Result Chesterford Hosts Annual ERBI Conference - Evening Event Chesterford Expands - 65,000 sq ft of Development Under Way April 2006 Nucleus Celebrates 1st Birthday March 2006 Galapagos enters a three-year collaboration with Roche Solexa Reports Fourth Quarter Financial Results Science week treats for after-school club Recovery Position - The first prelet in Cambridge in two years.... Arakis to Expand at Chesterford Research Park Galapagos Announces 2005 Annual Results February 2006 Solexa Transfers Listing to the Nasdaq National Market Solexa Announces Technical Milestones at the AGBT Conference Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Chesterford Hosts Annual ERBI Conference - Evening Event Chesterford Expands - 65,000 sq ft of Development Under Way April 2006 Nucleus Celebrates 1st Birthday March 2006 Galapagos enters a three-year collaboration with Roche Solexa Reports Fourth Quarter Financial Results Science week treats for after-school club Recovery Position - The first prelet in Cambridge in two years.... Arakis to Expand at Chesterford Research Park Galapagos Announces 2005 Annual Results February 2006 Solexa Transfers Listing to the Nasdaq National Market Solexa Announces Technical Milestones at the AGBT Conference Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Chesterford Expands - 65,000 sq ft of Development Under Way April 2006 Nucleus Celebrates 1st Birthday March 2006 Galapagos enters a three-year collaboration with Roche Solexa Reports Fourth Quarter Financial Results Science week treats for after-school club Recovery Position - The first prelet in Cambridge in two years.... Arakis to Expand at Chesterford Research Park Galapagos Announces 2005 Annual Results February 2006 Solexa Transfers Listing to the Nasdaq National Market Solexa Announces Technical Milestones at the AGBT Conference Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Nucleus Celebrates 1st Birthday March 2006 Galapagos enters a three-year collaboration with Roche Solexa Reports Fourth Quarter Financial Results Science week treats for after-school club Recovery Position - The first prelet in Cambridge in two years.... Arakis to Expand at Chesterford Research Park Galapagos Announces 2005 Annual Results February 2006 Solexa Transfers Listing to the Nasdaq National Market Solexa Announces Technical Milestones at the AGBT Conference Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Galapagos enters a three-year collaboration with Roche Solexa Reports Fourth Quarter Financial Results Science week treats for after-school club Recovery Position - The first prelet in Cambridge in two years.... Arakis to Expand at Chesterford Research Park Galapagos Announces 2005 Annual Results February 2006 Solexa Transfers Listing to the Nasdaq National Market Solexa Announces Technical Milestones at the AGBT Conference Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Solexa Reports Fourth Quarter Financial Results
Science week treats for after-school club
Recovery Position - The first prelet in Cambridge in two years....
Arakis to Expand at Chesterford Research Park
Galapagos Announces 2005 Annual Results
Solexa Transfers Listing to the Nasdaq National Market
Solexa Announces Technical Milestones at the AGBT Conference
Solexa Granted European Patent on Use of Single Molecules For Sequencing January 2006 Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Solexa Completes Second Closing of $65 Million Private Equity Financing Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research Solexa to Present 24th Annual JPMorgan Healthcare Conference
Solexa to Present 24th Annual JPMorgan Healthcare Conference